Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03429413 · ClinicalTrials.gov registry record · NA
Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial
A NA study, sponsored by University of Florida.
- Not yet
- Registry status
- NA
- Development phase
- 1,296
- Enrollment target
NCT03429413 is a NA study that has not yet begun recruiting, run by University of Florida. The registered enrollment target is 1,296 participants.
The verdict
NCT03429413, a NA study, has not yet begun recruiting, sponsored by University of Florida.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 1,296 participants
- Enrollment target
Study Summary
Human papillomavirus (HPV) vaccines have potential to prevent an average of 26,900 cancer cases each year in the United States, but vaccine coverage rates remain low. The study team has developed an electronic application (app), Protect Me 4, to help parents and providers assess and have more productive conversations about needed vaccines. The specific aims of this study are to: (1) evaluate the feasibility of implementing Protect Me 4, and (2) estimate preliminary efficacy of Protect Me 4 to increase HPV vaccine initiation (receipt of first dose).
Interventions
- BEHAVIORAL Protect Me 4 Application + External Quality Improvement Support
- BEHAVIORAL Protect Me 4 Application Alone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,296 participants |
| Start Date | 2026-09-15 |
| Est. Completion | 2027-09-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03429413
The ClinicalTrials.gov registry entry for NCT03429413 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 1,296 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Protect Me 4 Application + External Quality Improvement Support is the first listed.
NCT03429413 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03429413 about?
NCT03429413 is a clinical study titled "Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial". Human papillomavirus (HPV) vaccines have potential to prevent an average of 26,900 cancer cases each year in the United States, but vaccine coverage rates remain low. The study team has developed an electronic application (app), Protect Me 4, to help parents and providers assess and have more produc...
What is the current status of trial NCT03429413?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,296 participants. The study started on 2026-09-15. Estimated completion is 2027-09-15.
What interventions are being tested in trial NCT03429413?
The interventions under investigation include: Protect Me 4 Application + External Quality Improvement Support (BEHAVIORAL), Protect Me 4 Application Alone (BEHAVIORAL).
Who is sponsoring clinical trial NCT03429413?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.